Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts

被引:134
|
作者
Ogasawara, K
Benjamin, J
Takaki, R
Phillips, JH
Lanier, LL [1 ]
机构
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
[3] Int Med Ctr Japan, Res Inst, Div Clin Immunol, Dept Intractable Dis,Shinjuku Ku, Tokyo 1628655, Japan
[4] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA
[5] Schering Plough BioPharma, Palo Alto, CA 94304 USA
关键词
D O I
10.1038/ni1236
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Irradiation- resistant natural killer ( NK) cells in an F-1 recipient can reject parental bone marrow, and host NK cells can also prevent engraftment of allogeneic bone marrow. We show here that repopulating bone marrow cells in certain mouse strains expressed retinoic acid early inducible 1 proteins, which are ligands for the activating NKG2D NK cell receptor. Treatment with a neutralizing antibody to NKG2D prevented rejection of parental BALB/ c bone marrow in ( C57BL/ 6 x BALB/ c) F1 recipients and allowed engraftment of allogeneic BALB. B bone marrow in C57BL/ 6 recipients. Additionally, bone marrow from C57BL/ 6 mice transgenic for retinoic acid early inducible 1 epsilon was rejected by syngeneic mice but was accepted after treatment with antibody to NKG2D. If other stem cells or tissues upregulate expression of NKG2D ligands after transplantation, NKG2D may contribute to graft rejection in immunocompetent hosts.
引用
收藏
页码:938 / 945
页数:8
相关论文
共 50 条
  • [21] Human NKG2D ligand regulation of Natural Killer cell function and its implications in cancer and inflammation
    Dhar, Payal
    Wu, Jennifer
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Natural killer cell-mediated innate microvascular rejection
    Thaunat, Olivier
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (08) : 489 - 490
  • [23] POLYMORPHISMS OF NATURAL KILLER CELL RECEPTOR NKG2D AND CHILDHOOD LEUKEMIA SUSCEPTIBILITY
    Ucisik-Akkaya, Esma
    Dorak, M. Tevfik
    HUMAN IMMUNOLOGY, 2008, 69 : S90 - S90
  • [24] Human NKG2D ligand regulation of Natural Killer cell function and its implications in Cancer and Inflammation
    Dhar, Payal
    Wu, Jennifer
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [25] Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation
    Carapito, Raphael
    Aouadi, Ismail
    Ilias, Wassila
    Bahram, Seiamak
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [26] Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D Ligands by the histone deacetylase inhibitor sodium valproate
    Armeanu, S
    Bitzer, M
    Lauer, UM
    Venturelli, S
    Pathil, A
    Krusch, M
    Kaiser, S
    Jobst, K
    Smirnow, I
    Wagner, A
    Steinle, A
    Salih, HR
    CANCER RESEARCH, 2005, 65 (14) : 6321 - 6329
  • [27] Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity
    Cerboni, Cristina
    Neri, Francesca
    Casartelli, Nicoletta
    Zingoni, Alessandra
    Cosman, David
    Rossi, Paolo
    Santoni, Angela
    Doria, Margherita
    JOURNAL OF GENERAL VIROLOGY, 2007, 88 : 242 - 250
  • [28] The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation
    Lin, Christine M.
    Gill, Ronald G.
    Mehrad, Borna
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (11) : 3550 - 3560
  • [29] "Acquired" NKG2D Ligand Stimulates NK Cell-mediated Tumor Immunosurveillance
    Wang, Dongfang
    Gu, Xiuling
    Liu, Xinjun
    Liu, Xiaoman
    Wang, Bin
    Lao, Fengxue
    Fang, Min
    JOURNAL OF IMMUNOTHERAPY, 2019, 42 (06) : 189 - 196
  • [30] Differential requirement for NKG2D in the rejection of haplomismatched and MHC-I deficient bone marrow
    Benjamin, J. E.
    Lanier, L. L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 83 - 83